Compare AXGN & NGVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXGN | NGVT |
|---|---|---|
| Founded | N/A | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | 2013 | 2015 |
| Metric | AXGN | NGVT |
|---|---|---|
| Price | $55.80 | $53.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 3 |
| Target Price | $60.09 | ★ $88.67 |
| AVG Volume (30 Days) | ★ 2.0M | 349.7K |
| Earning Date | 10-28-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.10 |
| EPS | N/A | ★ 4.08 |
| Revenue | $225,208,000.00 | ★ $1,167,600,000.00 |
| Revenue This Year | $28.92 | N/A |
| Revenue Next Year | $28.37 | $0.99 |
| P/E Ratio | ★ N/A | $13.72 |
| Revenue Growth | ★ 20.21 | N/A |
| 52 Week Low | $26.92 | $49.15 |
| 52 Week High | $59.72 | $79.29 |
| Indicator | AXGN | NGVT |
|---|---|---|
| Relative Strength Index (RSI) | 66.73 | 24.31 |
| Support Level | $39.18 | N/A |
| Resistance Level | $59.72 | $77.60 |
| Average True Range (ATR) | 2.93 | 2.84 |
| MACD | 0.30 | -1.13 |
| Stochastic Oscillator | 68.56 | 1.53 |
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.